Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Holleran S, Tycko B, Leff T, Shachter N S
Division of Preventive Medicine and Nutrition, Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 W. 168th Street, New York, NY 10032, USA.
J Lipid Res. 1999 Jan;40(1):50-8.
Apolipoprotein (apo) C-I is a constituent of triglyceride-rich lipoproteins (TGRL) that interferes with their hepatic clearance. Functional polymorphism in the apoC-I gene has not been established. We determined that an Hpa I site variably present at -317 relative to the apoC-I gene is produced by a 4-bp CGTT insertion. The apoC-I Hpa I alleles showed an ethnically distinct pattern of linkage disequilibrium with the alleles of the adjacent apoE gene. The frequency of apoC-I Hpa I-positive (H2) with apoE varepsilon2 was 0. 98, without significant ethnic difference. In contrast, the frequency of H2 with apoE epsilon4 was 0.85 in European-Americans but only 0.55 in African-Americans (P < 0.001). The frequency of H2 with apoE epsilon3 was 0.02 in European-Americans and 0.08 in African-Americans (P < 0.001). African-American apoE epsilon3/epsilon3 carriers of apoC-I H2 had 19% lower fasting triglyceride levels than H1 homozygotes (P = 0.03) along with 18% higher HDL-cholesterol levels (P = 0.02). ApoB levels were 21% lower (P = 0.002). H2-allelic reporter-gene constructions showed 50% higher expression in transient transfection studies. We localized the source of this difference in expression to the CGTT insertion itself. Deletion studies of the H1 allele showed a negative transcriptional effect of the polymorphic region. An H1 oligodeoxynucleotide showed specific binding of a hepatoma-cell nuclear protein not evident with an H2 oligodeoxynucleotide. The H2 sequence may decrease the binding of a negatively acting transcription factor, leading to overexpression of apoC-I. This may produce a functional effect on lipoprotein levels but confirmation is needed in other populations.
载脂蛋白(apo)C-I是富含甘油三酯脂蛋白(TGRL)的一个组成部分,它会干扰这些脂蛋白的肝脏清除过程。apoC-I基因中的功能多态性尚未确定。我们发现,相对于apoC-I基因,在 -317 处可变存在的一个Hpa I位点是由一个4碱基对的CGTT插入产生的。apoC-I Hpa I等位基因与相邻的apoE基因的等位基因呈现出种族差异明显的连锁不平衡模式。apoC-I Hpa I阳性(H2)与apoE ε2的频率为0.98,无显著种族差异。相比之下,H2与apoE ε4的频率在欧裔美国人中为0.85,而在非裔美国人中仅为0.55(P < 0.001)。H2与apoE ε3的频率在欧裔美国人中为0.02,在非裔美国人中为0.08(P < 0.001)。非裔美国人中apoC-I H2的apoE ε3/ε3携带者空腹甘油三酯水平比H1纯合子低19%(P = 0.03),同时高密度脂蛋白胆固醇水平高18%(P = 0.02)。载脂蛋白B水平低21%(P = 0.002)。H2等位基因报告基因构建体在瞬时转染研究中显示出高50%的表达。我们将这种表达差异的来源定位到CGTT插入本身。对H1等位基因的缺失研究显示多态性区域具有负转录效应。一个H1寡脱氧核苷酸显示出一种肝癌细胞核蛋白的特异性结合,而H2寡脱氧核苷酸则未显示出这种结合。H2序列可能会减少负性作用转录因子的结合,导致apoC-I的过表达。这可能会对脂蛋白水平产生功能影响,但需要在其他人群中进行证实。